Prevalence of mesquite (prosopis species) allergy and efficacy of conventional allergen specific Immunotherapy (ASIT) to mesquite in Egyptian patients with perennial allergic rhinitis (PAR) 
Subjects, materials and methods
Two hundred adult PAR patients were evaluated by allergy prick skin testing (PST) against a panel of 15 different aeroallergens including mesquite. Patients exhibiting a positive PST response to mesquite only were subjected to mesquite conventional subcutaneous ASIT. All reagents were purchased from Omega Laboratories, CANADA. Informed consents, symptom and medication scores were obtained before and after ASIT.
Results
Eighty six patients exhibited a positive PST response to mesquite allergen. Out of these 38 patients were positive to mesquite allergen only. Significant improvement in symptom and medication scores were detected in 24/38 patients 4 months after the initiation of ASIT.
Conclusions
Mesquite pollen allergy is common among Egyptian PAR patients and ASIT with mesquite extract can reduce the burden of the disease in these patients. 
